August 06, 2025 a 08:01 am
EW: Fundamental Ratio Analysis - Edwards Lifesciences Corporation
Edwards Lifesciences Corporation is a leader in the healthcare sector, focusing on advanced solutions for structural heart diseases and critical care monitoring. The company's consistent innovation in transcatheter heart valve therapies and surgical heart solutions underscores its competitive stance. Despite challenges in ROE and ROA, EW's focus on cutting-edge products positions it for potential growth.
Fundamental Rating
The fundamental analysis provides a mid-tier overall score indicating stable financial health with room for improvement.
| Category | Score | Visualization |
|---|---|---|
| Overall | 2 | |
| Discounted Cash Flow | 3 | |
| Return on Equity | 1 | |
| Return on Assets | 1 | |
| Debt to Equity | 1 | |
| Price to Earnings | 3 | |
| Price to Book | 1 |
Historical Rating
The historical data reflects a slight improvement in the overall score over time.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-08-05 | 2 | 3 | 1 | 1 | 1 | 3 | 1 |
| Historic | 0 | 3 | 1 | 1 | 1 | 3 | 1 |
Analysts' Price Targets
Analysts' consensus remains bullish, anticipating a consistent price level.
| High | Low | Median | Consensus |
|---|---|---|---|
| 75 | 75 | 75 | 75 |
Analysts' Sentiment
Market sentiment is generally positive, with a majority of analysts recommending a "Buy".
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 28 | |
| Hold | 19 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Edwards Lifesciences Corporation is traversing a promising path in the healthcare sector, bolstered by its innovative product suite. Despite moderate fundamental scores, its strategic emphasis on cutting-edge technologies could catalyze future growth. However, investors should monitor potential risks linked to its financial metrics. The overall buy sentiment from analysts suggests confidence in the company’s prospective performance, making it a candidate for investment consideration.